|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-5-27
|
|
pubmed:abstractText |
To evaluate the efficacy and safety of adalimumab in inducing and maintaining remission of Crohn's disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1751-2980
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
© 2011 The Authors. Journal of Digestive Diseases © 2011 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and Blackwell Publishing Asia Pty Ltd.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
165-72
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21615869-Antibodies, Monoclonal,
pubmed-meshheading:21615869-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:21615869-Antirheumatic Agents,
pubmed-meshheading:21615869-C-Reactive Protein,
pubmed-meshheading:21615869-Controlled Clinical Trials as Topic,
pubmed-meshheading:21615869-Crohn Disease,
pubmed-meshheading:21615869-Humans,
pubmed-meshheading:21615869-Placebos,
pubmed-meshheading:21615869-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Efficacy and safety of adalimumab in Crohn's disease: meta-analysis of placebo-controlled trials.
|
|
pubmed:affiliation |
Department of Gastroenterology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai Institute of Digestive Disease, Shanghai, China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|
